SHIELDED-CELL & IMMUNOTHERAPY PAIRS Trademark

Trademark Overview


On Monday, July 4, 2022, a trademark application was filed for SHIELDED-CELL & IMMUNOTHERAPY PAIRS with the United States Patent and Trademark Office. The USPTO has given the SHIELDED-CELL & IMMUNOTHERAPY PAIRS trademark a serial number of 79347676. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, October 23, 2023. This trademark is owned by CIMEIO THERAPEUTICS AG. The SHIELDED-CELL & IMMUNOTHERAPY PAIRS trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical products for gene and cell therapy

Gene and cell therapy services; consultant services in the fields of gene therapy and cell therapy

Pharmaceutical research and development services in the fields of gene therapy and cell therapy; medical and pharmaceutical research and development services, all in the fields of gene therapy and cell therapy; research services relating to pharmaceutical products for gene and cell therapy; biochemistry research services relating to cell therapy and gene therapy
shielded-cell & immunotherapy pairs

General Information


Serial Number79347676
Word MarkSHIELDED-CELL & IMMUNOTHERAPY PAIRS
Filing DateMonday, July 4, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, October 23, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical products for gene and cell therapy
Pseudo MarkSHIELDED CELL AND IMMUNOTHERAPY PAIRS
Goods and ServicesGene and cell therapy services; consultant services in the fields of gene therapy and cell therapy
Goods and ServicesPharmaceutical research and development services in the fields of gene therapy and cell therapy; medical and pharmaceutical research and development services, all in the fields of gene therapy and cell therapy; research services relating to pharmaceutical products for gene and cell therapy; biochemistry research services relating to cell therapy and gene therapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 19, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 19, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 19, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCIMEIO THERAPEUTICS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Thursday, August 18, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, August 19, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 23, 2022APPLICATION FILING RECEIPT MAILED
Friday, February 10, 2023ASSIGNED TO EXAMINER
Friday, February 17, 2023NON-FINAL ACTION WRITTEN
Saturday, February 18, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, April 6, 2023REFUSAL PROCESSED BY MPU
Thursday, April 6, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, May 2, 2023REFUSAL PROCESSED BY IB
Monday, October 23, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, October 23, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, October 23, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, January 24, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 24, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, February 13, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, October 24, 2024FINAL DISPOSITION NOTICE SENT TO IB
Thursday, October 24, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, November 9, 2024FINAL DECISION TRANSACTION PROCESSED BY IB